Three proteins were commonly identified using the three algorithms as relevant in classifying EVs derived from patients with a melanoma diagnosis compared to those from healthy controls: specifically, Proteoglycan 4 (PRG4), Apolipoprotein C4 (APOC4) and Haptoglobin-Related Protein (HPR). Here, PRG4 is linked to melanoma.